Overview A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension Status: Completed Trial end date: 2014-06-01 Target enrollment: Participant gender: Summary The objective of this Phase 1 study is to evaluate the VISION5 Product's safety and efficacy. Phase: Phase 1 Details Lead Sponsor: ForSight Vision5, Inc.